Direct Filing of Valsartan Cases into the MDL Granted
Direct Filing of Valsartan Cases into the MDL Granted
Introduction
U.S. District Judge Robert B. Kugler, presiding over all federal valsartan recall lawsuits, allowed the direct filing of new cases into the multidistrict litigation(MDL) established in New Jersey, where all similar claims are consolidated for pretrial proceedings.
Judge Kugler issued a case management order on April 9, in which the process for the direct filing was outlined. There are nearly 50 product liability lawsuits filed against generic valsartan drug manufacturers and distributors, each with similar claims that the blood pressure drug distributed all these years were tainted with cancer-causing impurities, including N-nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), which are supposedly by-products of the drug's manufacturing process.
Comments
Latest News
Cencora Directors Settle Opioid Oversight Case for $111M
Categories: Opioids
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…
Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients
Categories: Philips CPAP/BiPAP/ASV Sleep Apnea Machines
A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…
FDA Adds New Warnings on Long-Term Opioid Risks
Categories: Opioids
Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.
…